Oral Miltefosine for the Treatment of Pediatric Cutaneous Leishmaniasis in Colombia

NCT00487253 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

150

Enrollment

OTHER

Sponsor class

Conditions

Cutaneous Leishmaniasis

Interventions

DRUG: Miltefosine
DRUG: Meglumine antimoniate

Sponsor

Centro Internacional de Entrenamiento e Investigaciones Médicas

Collaborators

[object Object]
[object Object]
[object Object]